메뉴 건너뛰기




Volumn 285, Issue 5435, 1999, Pages 1853-1855

Regulation of 'nutraceuticals'

Author keywords

[No Author keywords available]

Indexed keywords

NUTRACEUTICAL AGENT; UNCLASSIFIED DRUG; VITAMIN;

EID: 0033578922     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.285.5435.1853     Document Type: Short Survey
Times cited : (331)

References (11)
  • 1
    • 0345135653 scopus 로고    scopus 로고
    • Dietary Supplement Health and Education Act (DSHEA, Public Law 103-417, 25 October 1994; Codified at 42 USC 287C-11)
    • Dietary Supplement Health and Education Act (DSHEA, Public Law 103-417, 25 October 1994; Codified at 42 USC 287C-11).
  • 2
    • 0344705075 scopus 로고    scopus 로고
    • P. Kurtzweil, http://vm.cfsan.fda.gov/~dms/fdsupp.html (1999).
    • (1999)
    • Kurtzweil, P.1
  • 4
    • 0039057300 scopus 로고    scopus 로고
    • Natural products issue
    • M. R. Vogel, Natural products issue, Pharm. Today 4, 14 (1998).
    • (1998) Pharm. Today , vol.4 , pp. 14
    • Vogel, M.R.1
  • 6
    • 0000046715 scopus 로고    scopus 로고
    • Food and Drug Administration, Proposed rule, dietary supplements containing ephedrine alkaloids
    • 4 June 1997
    • Food and Drug Administration, Proposed rule, dietary supplements containing ephedrine alkaloids, Fed. Regist. 62 (107, 4 June 1997), 30677 (1997); T. B. Klepser and M. E. Klepser, Am. J. Health Syst. Pharm. 56, 125 (1999).
    • (1997) Fed. Regist. , vol.62 , Issue.107 , pp. 30677
  • 7
    • 0033555737 scopus 로고    scopus 로고
    • Food and Drug Administration, Proposed rule, dietary supplements containing ephedrine alkaloids, Fed. Regist. 62 (107, 4 June 1997), 30677 (1997); T. B. Klepser and M. E. Klepser, Am. J. Health Syst. Pharm. 56, 125 (1999).
    • (1999) Am. J. Health Syst. Pharm. , vol.56 , pp. 125
    • Klepser, T.B.1    Klepser, M.E.2
  • 8
    • 0039057297 scopus 로고    scopus 로고
    • Adverse events associated with ingestion of gamma-butyrolactone - Minnesota, New Mexico, and Texas, 1998-1999
    • Adverse events associated with ingestion of gamma-butyrolactone - Minnesota, New Mexico, and Texas, 1998-1999; Morb. Mortal. Wkly. Rep. 481, 37 (1999).
    • (1999) Morb. Mortal. Wkly. Rep. , vol.481 , pp. 37
  • 10
    • 0004915120 scopus 로고    scopus 로고
    • 6 February 1997
    • Fed. Regist. 62 (25, 6 February 1997), 5699 (1997).
    • (1997) Fed. Regist. , vol.62 , Issue.25 , pp. 5699
  • 11
    • 0344273265 scopus 로고    scopus 로고
    • http://vm.cfsan.fda.gov/~dms/supplmnt.html (1999).
    • (1999)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.